These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 7629984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
    Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F.
    AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
    [Abstract] [Full Text] [Related]

  • 4. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA, Obregón E, Navarro J, Börner C, Gurbindo MD, Sampelayo TH, Fernández-Cruz E.
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
    Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J.
    J Infect Dis; 2002 Oct 15; 186(8):1181-5. PubMed ID: 12355373
    [Abstract] [Full Text] [Related]

  • 7. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA, Lepri AC, Devereux H, Phillips AN, Loveday C, Lee CA.
    J Infect Dis; 2001 Aug 15; 184(4):511-4. PubMed ID: 11471111
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T.
    An Med Interna; 1999 Sep 15; 16(9):447-50. PubMed ID: 10609356
    [Abstract] [Full Text] [Related]

  • 10. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T, Lecha N, Rubio Rivas C.
    An Med Interna; 2000 Oct 15; 17(10):533-7. PubMed ID: 11109648
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J.
    AIDS Rev; 2002 Oct 15; 4(2):83-92. PubMed ID: 12152521
    [Abstract] [Full Text] [Related]

  • 14. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
    de Wolf F, Spijkerman I, Schellekens PT, Langendam M, Kuiken C, Bakker M, Roos M, Coutinho R, Miedema F, Goudsmit J.
    AIDS; 1997 Dec 15; 11(15):1799-806. PubMed ID: 9412697
    [Abstract] [Full Text] [Related]

  • 15. Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia.
    Ravina A, Ficarra G, Chiodo M, Mazzetti M, Romagnani S.
    J Oral Pathol Med; 1996 Mar 15; 25(3):108-11. PubMed ID: 9148036
    [Abstract] [Full Text] [Related]

  • 16. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
    Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR.
    Ann Intern Med; 1997 Jun 15; 126(12):946-54. PubMed ID: 9182471
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV.
    N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191
    [Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group.
    AIDS Res Hum Retroviruses; 2000 Aug 10; 16(12):1123-33. PubMed ID: 10954887
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
    Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, Shaw GM, Busch MP.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul 01; 9(3):305-10. PubMed ID: 7788430
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.